Literature DB >> 12742276

Infrastructure of radiotherapy in the Netherlands: evaluation of prognoses and introduction of a new model for determining the needs.

Ben J Slotman1, Jan W H Leer.   

Abstract

BACKGROUND AND
PURPOSE: In the Netherlands, the radiotherapy infrastructure is regulated by a Governmental license system. This requires timely and realistic prognostication of the needs for radiotherapy. In the present study, the latest prognoses (1993) and the realized changes in infrastructure are evaluated and a new prognosis for the period until 2010, which has been calculated using a new model, is presented.
MATERIALS AND METHODS: Data on cancer incidence and use of radiotherapy were obtained from various published national reports and from a survey of all radiotherapy departments.
RESULTS: The cancer incidence over the period 1993-1997 was about 10% higher than predicted. In 1996 and 1997, the percentage of new cancer patients treated with radiotherapy was 45.6 and 48.2%, respectively. The absolute number of newly irradiated patients was about 10% higher than foreseen in the prognosis. The needs for radiotherapy infrastructure not only depend on epidemiological data and changes in indications for radiotherapy, but also on changes in types of treatment with different workloads. A new model, which uses four categories for teletherapy and four categories for brachytherapy is described and a new prognosis for the required number of linear accelerators and staff up to the year 2010 is presented.
CONCLUSION: The original prognosis on cancer incidence and radiotherapy patients underestimated the actual figures considerably. The new prognosis, based on a model, which not only accounts for an increase in number of patients, but also for changes in treatment techniques, is expected to more accurately predict and acquire the required radiotherapy capacity.

Entities:  

Mesh:

Year:  2003        PMID: 12742276     DOI: 10.1016/s0167-8140(03)00025-2

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  4 in total

1.  Preliminary analysis of the resources in brachytherapy in Europe and its variability of use.

Authors:  F Guedea; T Ellison; G Heeren; M Ventura; G François; J J Mazeron; B Cottier; J López Torrecilla; P Bilbao; M Taillet; J M Borras
Journal:  Clin Transl Oncol       Date:  2006-07       Impact factor: 3.405

2.  Outcomes research: Radiotherapy capacity in Europe--time to even things out?

Authors:  Suresh Senan; Ben J Slotman
Journal:  Nat Rev Clin Oncol       Date:  2013-03-12       Impact factor: 66.675

3.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial.

Authors:  Wilfried Budach; Edwin Bölke; Rainer Fietkau; Andre Buchali; Thomas G Wendt; Wolfgang Popp; Christiane Matuschek; Horst Sack
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

4.  Accurate method for evaluating the duration of the entire radiotherapy process.

Authors:  Chenlei Guo; Peng Huang; Yexiong Li; Jianrong Dai
Journal:  J Appl Clin Med Phys       Date:  2020-07-25       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.